Manchester Science Partnerships invests in the future with £60m Citylabs expansion
Partnerships (MSP), the UK's leading science and technology park
operator, is to invest £60m in a major expansion of Citylabs, its
biomedical centre of excellence in a joint venture partnership with
Central Manchester University Hospitals NHS Foundation Trust
In a major vote of confidence for the Manchester city
region, the development will create Citylabs 2.0 and Citylabs 3.0
on the CMFT campus, in the heart of Manchester's Innovation
District - Corridor Manchester.
The new development will provide additional space to
enable biomedical companies to grow and co-create new health
products, in collaboration with the NHS and academia for the
benefit of patients. It is anticipated that when both
are completed and fully let Citylabs 2.0 and 3.0 will bring
additional economic growth in excess of £100 million and over 750
new jobs to the city.
The project is the first to be delivered by the Strategic
Property Partnership between MSP's parent company, Bruntwood, and
CMFT. Announced in March 2016, the partnership will support the
delivery of clinical care, research and innovation, as well as the
future development of CMFT's estate.
Rowena Burns, Chief Executive of Manchester Science
Partnerships said: "It is entirely fitting that we are making this
announcement as part of ESOF- an international event which is
focused on innovation and collaboration - two of the pillars on
which our business is built.
"Manchester's Innovation District will be strengthened
further by the development of Citylabs 2.0 and 3.0. Our investment
will help create fresh ideas, partnerships and scientific
discovery. Above all, Manchester and the North West offer investors
outstanding access to talent, knowledge and clinical
Steve Mycio OBE, Chairman of Central Manchester University
Hospitals NHS Foundation Trust added: "By working together in this
way with industry, the NHS can ensure health technologies are
developed that deliver better outcomes more efficiently to meet
current and future needs of our patients and healthcare
"Citylabs 2.0 and 3.0 is our first scheme under the
Strategic Property Partnership that CMFT has formed with Bruntwood.
Its purpose is to help ensure that our hospital building and
facilities are developed in a flexible and modern way to facilitate
early access to new diagnostics and treatments.
"Earlier this year our campus received designation as a
Life Sciences Enterprise Zone. This will make Citylabs and our
campus an even more attractive place for business, especially spin
outs from the hospitals and universities."
Chris Oglesby, Chairman of Manchester Science Partnerships
and Chief Executive of Bruntwood added: "It is great to see our
pioneering Strategic Property Partnership with the NHS in
Manchester hitting the ground running.
"Our investment in Citylabs 1.0 has been a huge
success and we are confident that Citylabs 2.0 and 3.0 will be
similarly well received by businesses centred in bio-medical
research and innovation.
"Manchester's excellent connectivity, universities
and talent pool, combined with its spirit of enterprise means the
city is well placed to thrive in the coming years and we are
determined to be at the heart of this journey."
Sir Richard Leese, Leader of Manchester City Council said:
"Citylabs epitomises Manchester's proud tradition of cutting edge
research, one of our distinctive strengths.
"This major investment sends out a resounding message
that we remain an outward and forward-looking city in which those
who want to invest and create jobs can flourish."
Citylabs 1.0, which opened in September 2014 after a £25m
redevelopment, was fully let within 15 months of opening. It is on
track to generate more than 400 new jobs and contribute
an estimated £60 million a year to Manchester's economy.
The investment for the new development will be made in two
phases, subject to planning consent being received by the end of
Citylabs 2.0 and 3.0 will be located on the corner of
Oxford Road and Hathersage Road, opposite Whitworth Park, at the
southern gateway to Europe's largest clinical-academic
The £25m Citylabs 2.0 development will comprise 89,500 sq
ft of lab and office space and subject to planning permission being
granted, construction work will begin in spring 2017, with
completion expected in summer 2018.
Citylabs 3.0 will span 112,000 sq ft and integrate the
development of 89,000 sq ft of new buildings with the Old Saint
Mary's Hospital, an existing listed Victorian building, comprising
23,000 sq ft. Construction is planned to start in summer 2018
and is due to be completed in 2020.
The £35m project includes the restoration of a currently
unused former chapel on the site, which is ear-marked for a café/
dining area with the potential for meeting room facilities, as well
as extensive external landscaping and the provision of new gardens
for the enjoyment of Citylabs occupiers and other users of the
For any enquiries, please email